Clinical Research Directory
Browse clinical research sites, groups, and studies.
CREO - Microwave Ablation Feasibility Study
Sponsor: Banner Health
Summary
The goal of this study is to assess the overall success of energy delivery during treatment using the ultrasound guided microwave ablation device in patients with locally advanced, unresectable, or metastatic cancer. Secondly, this study aims to explore the procedural/clinical safety of treatment with the device and the antitumor effect following treatment with the device.
Official title: Investigator-Initiated Feasibility Study of a Novel Endoscopic Ultrasound Guided Microwave Ablation Device in Patients With Locally Advanced, Unresectable, or Metastatic Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2026-02-19
Completion Date
2028-08
Last Updated
2026-09-14
Healthy Volunteers
No
Conditions
Interventions
EUS-Guided MWA Device
The rationale of this study is to generate preliminary data on the functionality and safety of Creo's MicroBlate™ Fine device when used under EUS guidance. The results generated from this study will inform any decisions regarding subsequent pivotal trials and may support the integration of this approach into clinical practice for anatomically challenging tumors.
Locations (7)
Banner MD Anderson Cancer Center and Gateway Hospital
Gilbert, Arizona, United States
Cedars Sinai
Los Angeles, California, United States
Rush University Medical Center
Chicago, Illinois, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
University of Tennessee Medical
Knoxville, Tennessee, United States
Memorial Hermann-Texas Medical Center
Houston, Texas, United States
West Virginia University Medicine
Morgantown, West Virginia, United States